Q: Hi 5i, thoughts on quarter and guidance pls and thx. Is it still on your small/mid cap favorite list? If yes where would you list in your top 5 ( pls list) choices?
5i Research Answer:
WELL EPS was 5c, off estimates of 5.5c; revenue of $251.7M beat estimates of $247M. EBITDA of $32.7M beat estimates by 2%. Gross margin was 44.6%. Revenue guidance was raised to $985M+, from $970M+. EBITDA range was also raised. Its $1B run rate was achieved ahead of plan. Revenue rose 27%; EBITDA rose 16%. Patient visits increased 41%. It was a solid quarter/outlook and the stock finally made a move today.
We would consider: TVK, HPS.A, WELL, TCS, VHI as favourites in order.